Abstract:Skeletal problems and osteoporosis occur in up to 50% affected neurofibromatosis type 1 (NF1) humans. Inactivation of neurofibromin results in deregulation of Ras signal transduction. Little is known of bone biology in humans with NF1. The goal of our work was to determine if loss-of-function of Nf1 gene was associated with altered bone homeostasis and Ras signal transduction. Because homozygous Nf1 mice are embryonically lethal, heterozygote Nf1 (Nf1+/-) male mice were used to investigate skeletal phenotypes and osteoprogenitor functions, using standard in vivo and in vitro assays. We found that bone mass and geometry of Nf1+/- mice did not differ from wild type controls, despite a trend to less bone formation. Nf1+/- committed osteoprogenitors from femur metaphysis exhibited premature apoptosis and higher proliferation. Ras signaling was activated in primary Nf1+/- bone marrow-inducible osteoprogenitors. Inducible osteoprogenitors exhibited lower induction of osteoblast differentiation, assessed as alkaline phosphatase positive CFU-f. A screen of osteoblast marker genes showed a selective increase in osteopontin (OPN) mRNA and protein expression in these cells. OPN protein was increased in Nf1+/- bone, especially in cortical bone matrix. Because bone cell abnormalities in Nf1 haploinsufficiency were detected in vitro, redundant pathways must compensate for the deregulation of Ras signaling in vivo to maintain normal bone mass and function in vivo. Our in vitro data revealed that neurofibromin and its control of Ras signaling are required for osteoprogenitor homeostasis.

Rescue of a Drosophila NF1 Mutant Phenotype by Protein Kinase A

A Novel Neuroprotective Role of Phosphatase of Regenerating Liver-1 Against CO2 Stimulation in Drosophila

Ral A, Via Activating the Mitotic Checkpoint, Sensitizes Cells Lacking a Functional Nf1 to Apoptosis in the Absence of Protein Kinase C

Neurofibromin Regulates G Protein–stimulated Adenylyl Cyclase Activity

Effect of Neurofibromatosis Type I Mutations on a Novel Pathway for Adenylyl Cyclase Activation Requiring Neurofibromin and Ras.

Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides.

Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila

Regulation of the Viability of Nf1 Deficient Cells by PKC Isoforms

A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor

Induction of Mitotic Catastrophe by PKC Inhibition in Nf1-deficient Cells.

The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice

Drosophila Contributions towards Understanding Neurofibromatosis 1

A neurofibromatosis-1-regulated pathway is required for learning in Drosophila

A chemical-genetics approach to study the role of atypical protein kinase C in Drosophila

Conditional deletion of Pten tumor suppressor gene and activation of K Ras oncogene result in the development of Neurofibromatoses

Drosophila phosphoinositide-dependent kinase-1 regulates apoptosis and growth via the phosphoinositide 3-kinase-dependent signaling pathway

Hyperactivation of P21ras and PI3K Cooperate to Alter Murine and Human Neurofibromatosis Type 1-Haploinsufficient Osteoclast Functions.

PFTK1 kinase regulates axogenesis during development via RhoA activation

Neurofibromin and Its Inactivation of Ras Are Prerequisites for Osteoblast Functioning

Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse

ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities